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addition, anatomic studies of the plantar artery
determine it to be present in at least 80% of patients
with little variation in the anatomic relationship to
surrounding structures.2 Thus, PBAs are possible
bypass targets for distal revascularization.
The refinement of infrainguinal reconstruction
techniques, the explosion in local wound care
options, and improvements in perioperative patient
care justify an aggressive approach to limb salvage in
the overwhelming majority of ambulatory patients
with critical lower extremity ischemia. As the fre-
quency of all infrainguinal reconstructions increase,
so does the opportunity for bypass to distal pedal
and plantar branch arteries. Such bypasses may
account for up to 20% of reconstructions.3 Andros3
described the order of frequency of distal target sites
as anterior tibial/dorsalis pedis, posterior tibial
(PT)/common plantar artery, lateral/medial plantar
artery, and lateral tarsal artery. Operative principles
In 1988, Lea Thomas et al1 described adequate
visualization of plantar arteries during conventional
arteriography in more than 80% of cases, with partial
visualization in an additional 13%. With advances in
imaging technology, the ability to interrogate pedal
branch arteries (PBAs) now approaches 100%. In
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Pedal branch artery bypass: 
A viable limb salvage option
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Purpose: We reviewed our experience with pedal branch artery (PBA) bypass to confirm
the role of these target arteries for limb salvage and to identify patient and technical fac-
tors that may be associated with graft patency and limb salvage.
Methods: In this retrospective study we analyzed 24 vein grafts to PBAs performed from
1988 to 1998 for limb salvage in 23 patients who had no suitable tibial, peroneal, or
dorsal pedal target arteries. These PBA grafts were compared with 133 perimalleolar
posterior tibial, defined at or below the ankle, or dorsalis pedis bypass grafts performed
contemporaneously; the Kaplan-Meier life table was used in the analysis of graft patency
and limb salvage. Life table analyses and logistic regression analysis of prognostic patient
variables were also performed.
Results: The PBA bypass represented 3% of infrainguinal revascularizations for chronic
critical limb ischemia at our institution over the study period. Patients who received PBA
bypasses were more likely to be male (92% vs 69%, P = .02) with lower incidences of overt
coronary artery disease (33% vs 50%, P = .12) and stroke (0% vs 15%, P = .04), and a
higher incidence of end-stage renal disease (21% vs 8%, P = .06) than those undergoing
perimalleolar bypass. Seventeen percent of PBA bypasses were performed with the ante-
rior lateral malleolar artery, a vessel not previously described as a common bypass target.
Two-year primary patency and limb salvage for PBA versus perimalleolar bypass was 70%
versus 80% (P = .16) and 78% versus 91% (P = .28), respectively. Patency and limb sal-
vage rates were no different in bypasses with above-knee or below-knee inflow arteries.
Conclusion: An autogenous vein bypass to the PBA, though rarely required, provides
acceptable primary patency and limb salvage when compared with perimalleolar tibial
artery bypass when no suitable, more proximal target arteries are available. The PBA
bypass should be considered before major amputation is undertaken. (J Vasc Surg
2000;32:1071-9.)
described include the use of short grafts from the
most distal inflow site possible; an aggressive search
for usable PBAs, particularly in diabetic patients with
isolated tibioperoneal disease and a palpable
popliteal pulse; and attention to wound healing and
rehabilitation, with the ultimate goal of complete
restoration of ambulatory status. With such an
aggressive approach, Veith et al4 observed reduc-
tions of primary major amputation rates from 41% to
5% and of total amputation rates from 49% to 14%.
Because of the rarity of patients who require PBA
bypass and the infrequency of reports in which expe-
rience with this technique is described, few surgeons
consider PBA bypass as a reasonable revasculariza-
tion alternative. We compared our experience with
PBA bypass with more conventional perimalleolar
artery bypasses to confirm the utility of PBA bypass
in lower extremity salvage and to identify patient- or
technique-related factors that may predict graft
patency and limb salvage.
METHODS
All hospital and office records were retrospec-
tively reviewed for patients undergoing autogenous
vein bypass to the perimalleolar tibial arteries and
PBAs for treatment of critical limb ischemia at the
Dartmouth-Hitchcock Medical Center from 1988
to 1998. Vein bypasses performed to target arteries
proximal to this level or those with synthetic con-
duits were excluded from further review. Patients
were then divided into two groups (PBA or peri-
malleolar) according to bypass outflow target. PBAs
were defined as any tarsal, plantar, and anterior lat-
eral malleolar arteries. The perimalleolar arteries
were defined as the PT artery at or distal to the
medial malleolus and the dorsal pedal artery.
Patients were selected for operation on the basis
of the presence of critical limb ischemia as defined by
Rutherford et al.5 Arterial anatomy and operative
planning were confirmed with preoperative noninva-
sive studies, contrast arteriography, duplex ultra-
sound scan arterial mapping, or a combination of
these methods. The in situ saphenous vein (ISSV)
was used preferentially. With translocated, reversed,
or nonreversed vein, composite grafts of the greater
saphenous, lesser saphenous, or arm vein were used
when the greater saphenous vein was inadequate or
unavailable for use as an uninterrupted in situ bypass
graft. Short bypass grafts were used when popliteal
or tibial arteries, suggested to be adequate for inflow
by preoperative evaluation, were confirmed to be
adequate intraoperatively. Angioscopy was uniformly
used in all cases to evaluate the adequacy of the vein
for bypass and to ensure successful vein valve lysis in
nonreversed veins. Completion intraoperative con-
trast or duplex scan arteriography confirmed techni-
cal adequacy of each bypass at the time of surgery.
Routine bypass graft surveillance included
duplex scan imaging at 3-month intervals during the
first postoperative year and at 6-month intervals
thereafter. Graft patency was determined with
inspection, palpation, duplex scan, or arteriography,
if necessary.5 Graft patency and limb salvage rates
were calculated from the date of surgery to the date
of thrombosis or amputation. For patients with
patent grafts and intact limbs, the date of their most
recent examination was used. Confirmation of sur-
vival status was accepted by telephone.
Patency and limb salvage rates between bypass
target artery groups were compared with the Kaplan-
Meier life table technique and the Mantel-Cox log-
rank analysis. The characteristics of these two groups
that pertained to preoperative demographics, comor-
bidities, and operative technique such as inflow
artery and conduit type were compared with the
Pearson χ2 analysis and Fisher exact tests. Univariate
life table comparisons were made for prognostic vari-
ables, followed by single and multiple logistic regres-
sion analysis and Cox proportional hazards model to
examine the significance, if any, of patient character-
istics such as age, sex, overt coronary artery disease,
diabetes, dialysis dependence, hypertension, smoking
history, cerebral vascular disease, and bypass charac-
teristics such as inflow or conduit as predictive of
bypass failure. Statistical significance was assumed for
a P value less than .05.
RESULTS
From 1988 to 1998, 763 infrainguinal bypass
grafts were performed at the Dartmouth-Hitchcock
Medical Center. The study group consisted of 24
bypass grafts (3%) performed in 23 patients with the
PBA as the outflow target for revascularization. For
comparison, 133 (17%) autogenous vein bypasses
were performed to the perimalleolar arteries during
the same time interval. Bypass grafts that were per-
formed to target arteries proximal to the ankle or
that included synthetic conduit (n = 606) were
excluded from further study.
Patient demographics. The 23 patients in the
PBA bypass group had a significantly higher propor-
tion of males compared with the perimalleolar group
(92% vs 69%, P = .02) (Table). In addition, there
were fewer patients with a history of previous stroke
(cerebrovascular accident [CVA]) (0% vs 15%, P =
.04), a trend toward less overt coronary artery dis-
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ease (33% vs 50%, P = .12) and more dialysis depen-
dent renal failure (DDRF) (21% vs 8%, P = .06) in
the PBA group. The groups were otherwise well
matched with respect to age and diabetes, hyperten-
sion, and smoking history; there were no other rele-
vant comparisons reaching statistical significance.
The indication for operation in all patients in the
study was limb salvage.
Bypass characteristics. The 24 procedures to PBA
outflow included bypasses to the lateral plantar (9),
medial plantar (5), anterior lateral malleolar (4) (Fig
1), lateral tarsal (5), and medial tarsal (1) arteries. The
perimalleolar grafts included bypass to the PT (74) and
dorsalis pedis arteries (59). Inflow origin for the PBA
bypasses included the common femoral artery (2), the
superficial femoral/above-knee (AK) popliteal artery
(11), the below-knee (BK) popliteal artery (4), the PT
artery (5), and the anterior tibial artery (2). By com-
parison, inflow arteries for the perimalleolar tibial
artery bypasses included the common femoral artery
(82), the superficial femoral/above-knee popliteal
artery (32), the below-knee popliteal artery (13), the
anterior tibial artery (3), and the PT artery (3). The
PBA bypasses originated above the knee and below the
knee in equal distribution (50% each), whereas peri-
malleolar bypasses originated above the knee in 86% of
cases (P < .0001).
The various conduits used in PBA bypasses were
ISSV (9); translocated, reversed saphenous vein
(RSV) (10); arm vein (2); composite saphenous and
arm vein (2); and nonreversed/transposed saphe-
nous vein (1). The distribution of conduits used in
the perimalleolar bypass group was ISSV (108),
reversed saphenous vein (7), arm vein (6), and com-
posite (12). The perimalleolar group had a signifi-
cantly higher proportion of ISSV bypass (P < .0001).
Life table analysis. Two-year primary graft
patency in the PBA bypass graft group was 70% ±
10%. Comparatively, 2-year primary graft patency
for perimalleolar grafts was slightly higher at 80% ±
4% (P = .16; Fig 2, A). Two-year limb salvage was
slightly lower in the PBA group when compared
with the perimalleolar group at 78% ± 9% and 91% ±
3% (P = .28, Fig 2, B). Most PBA bypass grafts that
failed did so within the first year. No additional
interventions were used to maintain PBA graft
patency because most grafts failed before surveil-
lance evidence indicated a potential threat. As such,
primary assisted and secondary patency rates were
equivalent to the primary patency reported for PBA
grafts. Two-year patency and limb salvage were used
for comparison because after 2.3 years, SEs for
patency exceed 10%.
For all patients, 2-year primary graft patency was
similar regardless of whether the inflow artery was
above or below the knee (80% ± 4% vs 76% ± 8%, P
= .63). For each of the outflow groups, no statistical
difference in patency found through multivariate
analysis whether the inflow artery was above or
below the knee (PBA: 74% ± 13% vs 67% ± 14%, P
= .80; perimalleolar: 79% ± 4% vs 83% ± 9%, P =
.99). Likewise, the inflow artery had no influence on
2-year limb salvage for the group as a whole (AK:
90% ± 3% vs BK: 85% ± 7%, P = .62), the PBA group
(AK: 83% ± 11% vs BK: 75% ± 12%, P = .51), or the
perimalleolar group (AK: 90% ± 3% vs BK: 90% ±
10%, P = .84).
Only 38% of PBA bypasses used the ISSV as a
conduit. Although the numbers were small, patency
at 1-year of PBA bypasses was slightly higher when
the ISSV was the bypass conduit (88% ± 12% vs 60%
± 13%, P = .06). Limb salvage in the PBA group was
also slightly higher at 1 year when the ISSV was used
(88% ± 12% vs 73% ± 11%, P = .33), although this
difference did not approach statistical significance.
Graft patency at 1 year in the group as a whole
was not negatively affected by the presence of
DDRF (83% ± 11% with DDRF vs 80% ± 4% with-
out, P = .85). The small overall number of patients
with DDRF (16) had an impact on this analysis.
None (0%) of the five patients with DDRF who
underwent PBA bypasses had graft failure or ampu-
tation. Among the 11 patients with DDRF who
underwent perimalleolar bypass, limb loss occurred
in three (27%). The small numbers involved pre-
cluded meaningful statistical analysis.
Logistic regression/Cox proportional hazards
model. All potentially prognostic patient variables
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Patient demographics
PBA Perimalleolar P value
Total bypass no. 24 133 —
Mean age (y) ± SEM 67.3 ± 2.3 68.8 ± .9 .53
Male:female 22 (92) 92 (69) .02
Comorbidities
CAD, n (%) 8 (33) 67 (50) .12
DM, n (%) 18 (75) 87 (65) .36
Smoking, n (%) 14 (58) 60 (45) .23
HTN, n (%) 18 (75) 93 (70) .25
DDRF, n (%) 5 (21) 11 (8) .06
CVA, n (%) 0 (0) 20 (15) .04
Indication
Limb salvage, n (%) 24 (100) 133 (100) N/A
Statistical analysis performed with Fisher exact testing and
Pearson χ2 method.
CAD, Coronary artery disease; CVA, cerebral vascular accident;
DDRF, dialysis dependent renal failure; DM, diabetes mellitus;
HTN, hypertension; PBA, pedal branch artery.
JOURNAL OF VASCULAR SURGERY
1074 Connors et al December 2000
Fig 1. Anterior lateral malleolar bypass. Preoperative AP (A) lateral (B) arteriograms demonstrating
anterior lateral malleolar artery branch of peroneal artery; intraoperative arteriogram demonstrating a
patent distal bypass to anterior malleolar artery. AP, Anterior-posterior.
A
B
were submitted to simple and multiple logistic regres-
sion, as well as univariate and multivariate Cox pro-
portional hazards analysis as possible predictors of
bypass failure. No variable (including age, sex, coro-
nary artery disease, diabetes, DDRF, smoking, hyper-
tension, or cerebrovascular disease) was found to be a
significant predictor either for the group as a whole or
within either PBA or perimalleolar subgroup. In addi-
tion, analysis of bypass characteristics (inflow, outflow,
and conduit) with the proportional hazards model
revealed no difference between above- and below-
knee inflow (hazards ratio 1.02; P = .97, 95% CI,
0.42–2.5) or between perimalleolar and PBA outflow
(hazards ratio 1.36; P = .47; 95% CI, 0.48–3.0), but
it suggested an advantage for ISSV bypass (hazard
ratio 0.52, P = .07; 95% CI, 0.22–1.05).
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Fig 2. A, Life table analysis for patency for PBA versus perimalleolar bypass. Kaplan-Meier life table
plot comparing cumulative graft patency for PBA bypass and perimalleolar bypass. The numbers in the
table correspond to number of bypasses at risk for failure in each group at beginning of each interval.
The dashed line indicates where SE exceeds 10% for the PBA bypass group. Statistical comparison per-
formed with Mantel-Cox log-rank analysis. B, Life table for limb salvage for PBA versus perimalleolar
bypass. Kaplan-Meier life table plot comparing cumulative limb salvage for PBA bypass and perimalle-
olar bypass. The numbers in table correspond to number of limbs at risk in each group at beginning of
each interval. SE was < 10% throughout for both groups. Statistical comparison performed with




In 1985 Veith et al and then later in 1988 Ascer
et al reported on patients in whom either primary or
secondary revascularization for limb salvage was car-
ried down to the PBA because of the lack of more
proximal outflow targets.6,7 In these patients,
bypasses to the plantar arch and lateral tarsal branches
provided acceptable graft patency and limb salvage.
In 1989, Andros et al8 described 20 grafts with lat-
eral plantar artery outflow and reported midterm
patency (1-3 years) and limb salvage rates of 73% and
89%, respectively. Likewise, Friedman et al9 reported
success in six patients with bypasses to the lateral
plantar artery.9 In 1991, Gloviczki et al,10 using a
microvascular surgical technique, reported 37
bypasses to the PBA with 1-year primary and sec-
ondary patency rates of 61% and 69%, respectively,
and a cumulative limb salvage rate of 82%.10 Later,
this same group reported the results of a prospective
study using the same approach for aggressive revas-
cularization for limb salvage. In 100 bypasses to
pedal, plantar, or tarsal outflow vessels, they
described a 3-year primary and secondary patency of
60% and 69%, respectively, with limb salvage in
79%.11 An aggressive approach to limb salvage with
“very distal bypass” was further supported by
Quinones-Baldrich et al,12 who described their expe-
rience with 35 bypasses to targets below the ankle
with patency and limb salvage rates of 72% and 89%,
respectively.12 They went on to report that ISSV
grafts and reversed vein grafts performed equally, as
did grafts with femoral, popliteal, or tibial inflow.
Our results with bypass to the PBA (70% graft
patency and 78% limb salvage at 2 years) are compa-
rable to those previously reported. One difference in
our experience is the addition of the anterior lateral
malleolar artery to the list of reliable PBA targets.
This vessel originates at the bifurcation of the pe-
roneal artery above the ankle and when patent, is
easily accessible, lying anteriorly over the lateral
malleolus. As shown in Fig 1, A, when present, the
artery can be marked with duplex scan or
approached simply with a vertical incision over the
mid portion of the lateral malleolus. The artery is
superficial. The dissection is straightforward.
The similarity of our results with the PBA to
those obtained with perimalleolar tibial arteries for
bypass targets is reassuring. It should encourage
those familiar with bypass to distal tibial arteries to
extend their list of possible target arteries to the PBA
for limb salvage procedures.
We confirm the findings of Veith et al as well as
other authors that short grafts originating below the
knee perform as well as above-knee inflow such that
the specific artery chosen for inflow does not have
an impact on graft patency or limb salvage.3,4,12,13
Mills et al14 reported 56 vein bypasses performed for
limb salvage originating from popliteal artery inflow
(25 AK, 31 BK) with tibial, dorsal pedal, or plantar
outflow. This represented 11% of their infrainguinal
reconstructions and led to 3-year patency and limb
salvage rates of 84% and 77%, respectively. They
found DDRF to be a strong predictor of failure of
limb salvage despite continued graft patency.
Verhelst et al15 reported 44 cases of BK popliteal-
distal bypass for limb salvage that comprised 8% of
their infrainguinal revascularizations. Their distal
outflow included tibial, perimalleolar, and PBA tar-
gets, with 3-year patency and limb salvage rates of
74% and 82%, respectively.
The number of patients with different conduit
types was too small to draw statistically meaningful
conclusions despite a slight patency advantage at 1
year in the ISSV group. Some investigators have
credited physiologic advantages to the ISSV tech-
nique.16-18 However, just as in our experience,
Quinones-Baldrich et al12 found a prognostic advan-
tage for ISSV and RSV bypasses compared with non-
reversed, translocated vein bypasses. They, however,
could not demonstrate overall superiority for either
the ISSV or RSV technique. In our study, because all
non–in situ venous conduits were translocated, these
translocated veins may be “disadvantaged” when
compared with veins, whether ISSV or RSV, which
we used in their region of origin.
The lack of effect of DDRF on patency and limb
salvage was surprising. Our bias, guided by our own
anecdotal experience and the published experience
of others, is that graft patency, foot salvage, and peri-
operative death are significantly and negatively
affected in patients with DDRF.19-21 Our results are
likely affected by this bias. We attempt limb salvage
revascularization in patients with DDRF only when
inflow, conduit, and target vessels as well as other
patient characteristics such as skin condition and car-
diac function are optimal.
In summary, our experience with PBA bypass
confirms the findings of others. These bypasses are
required in only a small percentage of patients under-
going infrainguinal revascularization. The patient
population comprises overwhelmingly male diabetic
smokers. Primary graft patency and limb salvage in
these patients are slightly lower but comparable to
those in patients who undergo lower extremity revas-
cularization with perimalleolar tibial arteries. The
anterior lateral malleolar artery is an additional PBA
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bypass target when more proximal tibial vessels are
unavailable. The choice of inflow artery does not
have an impact on graft patency or limb salvage. The
availability of the ISSV for conduit provided a mar-
ginally better result, but our institutional bias for this
technique must be acknowledged. In our small expe-
rience, with carefully selected patients, the presence
of DDRF did not have a negative impact on graft
patency or limb salvage in patients with PBA bypass.
We conclude that lower extremity revascularization
with vein grafts to PBA outflow is a viable alternative
to amputation when more proximal arterial targets
for bypass are unavailable.
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DISCUSSION
Dr Enrico Ascher, (Brooklyn, NY). I’d like to start by
thanking the program committee for the privilege of dis-
cussing this well-written paper by Drs Connors, Walsh and
their colleagues from Dartmouth.
The authors are to be congratulated on a careful analy-
sis of their experience with 24 vein bypasses through
branches of the tibial and peroneal arteries.
About 12 years ago, Frank Veith and I had the oppor-
tunity to introduce this extended approach to limb salvage
at the Southern Vascular Society. Then, the vascular com-
munity was quite skeptical and not very enthusiastic, to say
the least. After today’s presentation, I feel vindicated and
reassured that we were not wrong after all. Yes, vein
bypasses to branches of the tibial arteries are technically
feasible, not too difficult to perform, and durable. And
more importantly, the functional results in our own expe-
rience with over 50 such cases are excellent. I will resist,
however, the temptation to present my own paper and will
go directly to the questions for Dr Connors.
What is your selection criteria or criterion in choosing
a branch artery (ie, is the medial tarsal branch better than
the lateral malleolar branch)? We prefer the lateral plantar
branch whenever it is possible.
What are the anatomical landmarks used to identify
the lateral malleolar branch?
The causes of vein graft failure have not been
described in the manuscript. Because you follow the rigid
duplex scan protocol, I would like you to elaborate on the
causes of bypass failure in these high-risk outflow tracts.
Did you notice any difference in vein graft restenosis
in the pedal branch group when compared with the peri-
malleolar group?
I noticed that you have not used the pedal arch artery
as an outflow site. This can be facilitated by the removal of
a segment of the second metatarsal bone. Please comment. 
Now that you have confirmed the acceptable patency
and limb salvage results with these operations, would you
use a larger patent branch instead of a heavily and circum-
ferentially calcified parent artery? 
I have no comments regarding the apparent superior-
ity of the in situ vein technique since the authors them-
selves acknowledge in the manuscript that they
preferentially use this technique over reversed or translo-
cated vein. Thus, I assume that the best veins were used in
situ reflecting the better patency rates. 
I very much appreciate the opportunity to discuss this
paper and reading the manuscript. Thank you. 
Dr John P. Connors. I’d like to thank Dr Ascher for his
comments and questions and state that we are working
diligently in his shadow up at Dartmouth to validate this
operative technique. 
With regard to the first question on selection criteria, I
think in the initial throes of this investigation we were deal-
ing with very compromised and desperate situations. As
such, the initial evaluation of these patients was with arte-
riogram, and the selection bias for us was obviously (1)
whether they indeed had a conduit that would be prefer-
able to bypass to a pedal artery target and (2) whether a
pedal artery target was a viable option. Typically, we didn’t
actually objectively measure vessel diameters of arteries that
we saw in the arteriogram, however, subjectively our crite-
rion would be a pedal branch artery that was greater than
a millimeter in diameter. However, despite saying that, we
have some small target arteries that have performed better
than some of the larger arteries. 
Recently we’ve had the opportunity to evaluate our
targets on a more objective basis; namely, we’ve used pre-
operative as well as intraoperative duplex arteriography.
These data we’re currently analyzing, but we’ve evaluated
targets with respect to their end-diastolic velocity as well
as their peak systolic velocities. We have evolving data that
have allowed us to more objectively evaluate our possible
selection criteria for these arteries to try to differentiate
which artery might be a viable target option. 
The second question is what anatomic landmarks do
we use with regard to the locating anterolateral malleolar
branch? I think basically, as the name implies, it’s anterior,
or the dorsum of the foot, and just lateral to the lateral
malleolus. Typically, through an incision anterior and a
finger breadth medial from the lateral malleolus is where
we cut down and identify the artery for bypass. We expose
it, probably a centimeter in length prior to anastamosis.
And again, I think what’s critical in identifying the land-
marks is your preoperative studies. In the earlier aspects of
the study we used the arteriogram to guide our surgical
technique, but now we’ve used both preoperative and
intraoperative duplex to help facilitate the identification
and the exposure.
The third question is the cause of vein graft failure and
whether this pedal branch artery group is different from
any other distal bypass group. And I don’t think it is. I
think of the potential causes, as might have been elicited
from the survival analysis, the life table analyses, many of
our pedal branch arteries that went down, went down
early, typically within the first year; and even as this was
teased out, they failed within the first month. I think the
reasons for this were typically due to technical issues in
these early cases. I think our experience has grown, and I
think we’re more technically capable of handling these
bypasses. Another possible etiology is graft thrombosis
due to their limited distal outflow. I think the high resis-
tance outflow is an obvious complication that’s going to
perpetuate possible patency problems. 
As far as the approach to the removal of the segment
of the second metatarsal bone to expose the pedal arch
artery, we actually have no experience with this technique.
We’re aware of the technique as an option, but currently
we have not had the situation where we’ve had to actually
use that branch artery, but we are aware that it could
potentially be in our armamentarium. 
I think the question of whether we would use a large
patent branch versus a heavily calcified branch, I think that
is a preoperative evaluation technique, again on arteriog-
raphy, and we’re currently, like I said, attempting to
develop more objective criteria via the duplex data to eval-
uate those preoperatively. 
Dr Michael B. Silva, Jr. (Newark, NJ). John, did you
guys do your own angiography preoperatively or did the
interventional radiologist do that? 
Dr Connnors. I think initially, back in 1988, the inter-
ventionalists were performing a number of our preopera-
tive studies. However lately, I would say in the last 2 to 3




Dr Silva. I was wondering if you had trouble. One of the
classic problems, of course, is getting visualization of the
distal pedal circulation, distal to proximal occlusions. And
so, of course, you have, if your intervention radiologists are
doing it, to let them know what you want them to do.
Dr Connors. Right.
Dr Silva. But most of that was supplanted by intraoper-
ative angiography with proximal occlusion? 
Dr Connors. Well, I think the bridge to that has been
our preoperative duplex exam, too. It has identified a
pedal branch that is a potential target, and we’ve been
evaluating its consistency and sensitivity with intraopera-
tive arteriography.
Dr Anthony J. Comerota (Philadelphia, Pa). Could you
address that question that Dr Ascher asked. You’re obvi-
ously in favor of the in situ, so the better ipsilateral veins are
used in situ. How does that stack up against the good
saphenous vein, perhaps, that is not used in situ, or was your
analysis the in situ vein versus all other autogenous, that
includes arm veins, spliced arm veins and so forth?
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Dr Connors. Our experience is to use the in situ saphe-
nous vein primarily. And our evaluation did assess whether
the in situ saphenous vein was a viable conduit versus
other potential venous bypasses. 
Dr Comerota. That might include arm veins and
spliced veins? 
Dr Connors. Right.
Dr Comerota. So it’s not in situ versus saphenous vein
used nonreversed or reversed, it’s in situ versus all other
autogenous? 
Dr Connors. That’s correct.
Dr Mark E. Kahn (Englewood, NJ). This is a great
work. Thank you. A couple of technical questions.
Have you used the tourniquet to get control of some of
these tiny deep arteries above the knee or below the knee? 
And I’m also curious if you’ve done any flows to get
some idea, either by duplex or any other means, flow
meters, to find out what kind of flows in these veins you’re
getting to keep a vein open, or sometimes maybe will
allow for closure. We’ve seen that sometimes veins will stay
open for a prolonged period of time with even 20 cc or 30
cc of flow. But I’m curious if anybody has tried that at
your center.
Dr Connors. Thank you, Dr Kahn. Your first question
with respect to tourniquet use, as far as I’m aware, we have
not used tourniquets to facilitate any visualization or other
technical aspects of the intraoperative experience. 
And as far as assessing intraoperative flow hemodynam-
ics, we are currently not. Actually, in this study, in the 10
years that we did this study retrospectively, we did not assess
flow characteristics. However, now that we have imple-
mented the intraoperative duplex, again we have evidence—
I don’t want to present a paper that we haven’t worked on
extensively—but we’ve assessed the end-diastolic velocities
as well as the peak systolic velocities and that is what cur-
rently has been suspicious for showing higher patency rates
and possible facilitation of that target as far as a bypass. 
Dr Kahn. Thanks. One other little question. Have you
ever done an intraoperative arteriogram and found that
the runoff that you have, whether retrograde or other-
wise, is actually better than you had suspected and some-
times that may be related to why the vein graft stays open
longer? In other words, the intraoperative arteriogram is
actually better quality and maybe better vessels than the
preoperative. Thanks.
Dr Connors. I’m not aware that we’ve identified preop-
erative arteriography that has been inferior to our intraop-
erative evaluations. However, I will say that we have assessed
arterial targets directly vis-à-vis duplex as well as by direct
palpation and visualization that have not correlated exactly
with the arteriogram, and actually we found them to be a
little better as far as a target option. That having been said,
this doesn’t dictate patency rates, and the discordance
between these two observations, that we’re aware of.
JOURNAL OF VASCULAR SURGERY
Volume 32, Number 6 Connors et al 1079
